Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer

Rinat Bernstein-Molho, Tal Sella, Virginia Delucchi, Florence Coussy, Hee Jeong Kim, Sabine Linn, Antonio Di Meglio, Katarzyna Pogoda, Ava Kwong, Elisa Agostinetto, Jyoti Bajpai, Yannick Van Herck, Alberta Ferrari, Judith Balmana, Halle C.F. Moore, Fedro A. Peccatori, Ann H. Partridge, Melina Winocur, Tiphaine Renaud, Christine Rousset-Jablonski, Jeong Eon Lee, Angela Toss, Shani Paluch-Shimon, Stephanie M. Wong, Alexios Matikas, Cynthia Villarreal-Garza, Claudio Vernieri, Minna Lee, Deniz Can Guven, Wanda Cui, Kathryn J. Ruddy, Maria Vittoria Dieci, Robert Fruscio, Laura De Marchis, Zoe Kemp, Pedro A. Meireles, Maria Grazia Razeti, Maria Del Pilar Diz, Shelley E. Hwang, Fabio Puglisi, Florian Clatot, Rinat Yerushalmi, Natalia Cichowska-Cwalinska, Alessandra Chirco, Carmine De Angelis, Eva Blondeaux, Matteo Lambertini

Open source

DOI: 10.1016/j.ejca.2026.116937
Published: 2026-09
Container: European Journal of Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2026.116937,
  title = {Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer},
  author = {Rinat Bernstein-Molho and Tal Sella and Virginia Delucchi and Florence Coussy and Hee Jeong Kim and Sabine Linn and Antonio Di Meglio and Katarzyna Pogoda and Ava Kwong and Elisa Agostinetto and Jyoti Bajpai and Yannick Van Herck and Alberta Ferrari and Judith Balmana and Halle C.F. Moore and Fedro A. Peccatori and Ann H. Partridge and Melina Winocur and Tiphaine Renaud and Christine Rousset-Jablonski and Jeong Eon Lee and Angela Toss and Shani Paluch-Shimon and Stephanie M. Wong and Alexios Matikas and Cynthia Villarreal-Garza and Claudio Vernieri and Minna Lee and Deniz Can Guven and Wanda Cui and Kathryn J. Ruddy and Maria Vittoria Dieci and Robert Fruscio and Laura De Marchis and Zoe Kemp and Pedro A. Meireles and Maria Grazia Razeti and Maria Del Pilar Diz and Shelley E. Hwang and Fabio Puglisi and Florian Clatot and Rinat Yerushalmi and Natalia Cichowska-Cwalinska and Alessandra Chirco and Carmine De Angelis and Eva Blondeaux and Matteo Lambertini},
  year = {2026},
  journal = {European Journal of Cancer},
  doi = {10.1016/j.ejca.2026.116937},
  url = {https://doi.org/10.1016/j.ejca.2026.116937}
}

RIS

TY  - JOUR
TI  - Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer
AU  - Rinat Bernstein-Molho
AU  - Tal Sella
AU  - Virginia Delucchi
AU  - Florence Coussy
AU  - Hee Jeong Kim
AU  - Sabine Linn
AU  - Antonio Di Meglio
AU  - Katarzyna Pogoda
AU  - Ava Kwong
AU  - Elisa Agostinetto
AU  - Jyoti Bajpai
AU  - Yannick Van Herck
AU  - Alberta Ferrari
AU  - Judith Balmana
AU  - Halle C.F. Moore
AU  - Fedro A. Peccatori
AU  - Ann H. Partridge
AU  - Melina Winocur
AU  - Tiphaine Renaud
AU  - Christine Rousset-Jablonski
AU  - Jeong Eon Lee
AU  - Angela Toss
AU  - Shani Paluch-Shimon
AU  - Stephanie M. Wong
AU  - Alexios Matikas
AU  - Cynthia Villarreal-Garza
AU  - Claudio Vernieri
AU  - Minna Lee
AU  - Deniz Can Guven
AU  - Wanda Cui
AU  - Kathryn J. Ruddy
AU  - Maria Vittoria Dieci
AU  - Robert Fruscio
AU  - Laura De Marchis
AU  - Zoe Kemp
AU  - Pedro A. Meireles
AU  - Maria Grazia Razeti
AU  - Maria Del Pilar Diz
AU  - Shelley E. Hwang
AU  - Fabio Puglisi
AU  - Florian Clatot
AU  - Rinat Yerushalmi
AU  - Natalia Cichowska-Cwalinska
AU  - Alessandra Chirco
AU  - Carmine De Angelis
AU  - Eva Blondeaux
AU  - Matteo Lambertini
PY  - 2026
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2026.116937
UR  - https://doi.org/10.1016/j.ejca.2026.116937
ER  -

APA

Bernstein-Molho, R., Sella, T., Delucchi, V., Coussy, F., Kim, H. J., Linn, S., Meglio, A. D., Pogoda, K., Kwong, A., Agostinetto, E., Bajpai, J., Herck, Y. V., Ferrari, A., Balmana, J., Moore, H. C., Peccatori, F. A., Partridge, A. H., Winocur, M., Renaud, T., Rousset-Jablonski, C., Lee, J. E., Toss, A., Paluch-Shimon, S., Wong, S. M., Matikas, A., Villarreal-Garza, C., Vernieri, C., Lee, M., Guven, D. C., Cui, W., Ruddy, K. J., Dieci, M. V., Fruscio, R., Marchis, L. D., Kemp, Z., Meireles, P. A., Razeti, M. G., Diz, M. D. P., Hwang, S. E., Puglisi, F., Clatot, F., Yerushalmi, R., Cichowska-Cwalinska, N., Chirco, A., Angelis, C. D., Blondeaux, E., & Lambertini, M. (2026). Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116937

Source records

crossref · retrieved 2026-09-26T08:10:38.005Z